JPWO2022270621A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022270621A5
JPWO2022270621A5 JP2023530142A JP2023530142A JPWO2022270621A5 JP WO2022270621 A5 JPWO2022270621 A5 JP WO2022270621A5 JP 2023530142 A JP2023530142 A JP 2023530142A JP 2023530142 A JP2023530142 A JP 2023530142A JP WO2022270621 A5 JPWO2022270621 A5 JP WO2022270621A5
Authority
JP
Japan
Prior art keywords
lpar1
expression
pharmaceutical composition
osteosarcoma
ono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023530142A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022270621A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/025309 external-priority patent/WO2022270621A1/ja
Publication of JPWO2022270621A1 publication Critical patent/JPWO2022270621A1/ja
Publication of JPWO2022270621A5 publication Critical patent/JPWO2022270621A5/ja
Pending legal-status Critical Current

Links

JP2023530142A 2021-06-25 2022-06-24 Pending JPWO2022270621A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021106120 2021-06-25
PCT/JP2022/025309 WO2022270621A1 (ja) 2021-06-25 2022-06-24 骨肉腫及び神経膠腫の転移と増殖を抑制する新規治療薬

Publications (2)

Publication Number Publication Date
JPWO2022270621A1 JPWO2022270621A1 (https=) 2022-12-29
JPWO2022270621A5 true JPWO2022270621A5 (https=) 2025-06-27

Family

ID=84544444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023530142A Pending JPWO2022270621A1 (https=) 2021-06-25 2022-06-24

Country Status (5)

Country Link
US (1) US20240285587A1 (https=)
EP (1) EP4360650A4 (https=)
JP (1) JPWO2022270621A1 (https=)
CN (1) CN118055777A (https=)
WO (1) WO2022270621A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR108838A1 (es) * 2016-06-21 2018-10-03 Bristol Myers Squibb Co Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa

Similar Documents

Publication Publication Date Title
US10449193B2 (en) Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
JP6437119B2 (ja) 選択的ｓ１ｐ１レセプターアゴニストを含む薬学的合剤
Kennedy et al. BGP-15 improves aspects of the dystrophic pathology in mdx and dko mice with differing efficacies in heart and skeletal muscle
Parrinello et al. Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur)
WO2014134569A1 (en) Compositions and methods for treating amyotrophic lateral sclerosis in responders
Yuen et al. Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma
Ranek et al. Muscarinic 2 receptors modulate cardiac proteasome function in a protein kinase G-dependent manner
JP2023179435A (ja) 多発性骨髄腫治療
Weydt et al. Clinical trials in spinal and bulbar muscular atrophy—past, present, and future
JP2013544870A (ja) 肝障害のリスク管理に使用する薬剤の調製のためのドロネダロンの使用
Ren et al. Salidroside treatment decreases the susceptibility of atrial fibrillation in diabetic mice by reducing mTOR-STAT3-MCP-1 signaling and atrial inflammation
JPWO2022270621A5 (https=)
Yarbrough et al. Pharmacologic inhibition of intracellular caspases after myocardial infarction attenuates left ventricular remodeling: a potentially novel pathway
Linz et al. Pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut reduces atrial fibrillation susceptibility in obese spontaneously hypertensive rats
CN109562280B (zh) 复发-缓解型多发性硬化的诊断或预测因子
Shimizu et al. Sumatriptan provokes coronary artery spasm in patients with variant angina: possible involvement of serotonin 1B receptor
Liu et al. Janus hydrogels delivering low-density lipoprotein receptor-related protein 6 inhibitor enhance myocardial repair via m6A-dependent cuproptosis in bama pigs
JP6594899B2 (ja) 特発性肺線維症の治療方法
Fragni Identification of novel readouts to assess anti-fibrotic efficacy of new compounds in a bleomycin-induced pulmonary fibrosis mouse model
Durai et al. Impact of Cardiac Rehabilitation Involving Carers/Spouses on Quality of Life, Psychological Status and Self-Efficacy of Cardiac Patients
Çanga et al. OP-094 [AJC» Cardiac imaging-Echocardiography] Cardiac Myxoma: Fourteen-year experience of a Tertiary Reference Center
CN117442623A (zh) 4-[9-(6-氨基嘌呤基)]-2(s)-羟基丁酸甲酯的制药用途
Marchal et al. an, Verkerk
WO2025160615A1 (en) Methods of treating scleroderma
Bueno et al. [LB. 03.10] PHARMACOMETABOLOMIC ANALYZES OF FIVE ANTIHYPERTENSIVE DRUGS FROM HUMAN SERUM SAMPLES OF RESISTANT HYPERTENSIVE PATIENTS